CagriSema (Cagrilintide + Semaglutide) and Retatrutide are highly effective for weight loss, but differ in mechanisms. CagriSema combines amylin and GLP 1 effects, enhancing appetite suppression and Reta clinical trial data & dosing a must read Retatrutide (Reta) isn't just another GLP 1. It's a triple agonist peptide studied in Phase 3 trials for metabolic health targeting GLP 1, GIP, Retatrutide Dosing Guide: 1 12 mg Weekly Triple Agonist (2026) Retatrutide and Tirzepatide Dosage Guide: Effective Peptide Treatments Explained Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Tirzepatide vs. Retatrutide: Key Differences Explained